NARA Discovery
NARA Subscribed Scholarly Literature Discovery
Boolean search: climate AND coral · microplastic OR nanoplastic · plastic NOT freshwater · "marine heatwave"
Advanced Search
Topic searches article titles and abstracts. Starts a new search; publisher and year refine it.
Searches article titles and abstracts.
Accepts bare DOI, doi: prefix, or a doi.org URL.
Complete publisher name. Publisher imprints are grouped under their main publisher where applicable.
Exact match by full journal title or ISSN.
–
Refine Results Clear Filters
Collection
NARA Subscribed21
Publisher
Springer Nature21
Journal
European Journal of Clinical Pharmacology21
Publication Year
20261
20211
20181
20161
20152
20121
20112
20082
20072
20066
20021
20011
Janne T. Backman results 21 · Newest (Page 1/1, per page 25)
Export CSV Export RIS Export current results · up to 5,000 records
Author: Janne T. Backman ×Clear All Filters
Search Results
Early-career pre-congress meetings: investing in talent, transforming the future of clinical pharmacologyNARA Subscribed
European Journal of Clinical Pharmacology · 2026 · Vol. 82 · Issue 1 · Springer
Andrej Belančić; Kaisa Litonius; Noora Kulla; Robert Likić; Slobodan Janković; Dinko Vitezić; Janne T. Backman
View Details View Full Text
Incidence, preventability, and causality of adverse drug reactions at a university hospital emergency departmentNARA Subscribed
European Journal of Clinical Pharmacology · 2021 · Vol. 77 · Issue 4 · Springer
Mirjam Kauppila; Janne T. Backman; Mikko Niemi; Outi Lapatto-Reiniluoto
Purpose To investigate the characteristics of ADRs in patients admitting at the emergency room of a tertiary hospital. Methods We collected the patient records of 1600 emergency room visits of a university hospital in 2018. The patient files were studied retrospectively and all possible ADRs were identified and registered. Patient characteristics, drugs associated with ADRs, causality, severity, preventability, and the role of...
View Details View Full Text
Voriconazole greatly increases the exposure to oral buprenorphineNARA Subscribed
European Journal of Clinical Pharmacology · 2018 · Vol. 74 · Issue 12 · Springer
Mari Fihlman; Tuija Hemmilä; Nora M. Hagelberg; Janne T. Backman; Jouko Laitila; Kari Laine; Pertti J Neuvonen; Klaus T. Olkkola; Teijo I. Saari
View Details View Full Text
Voriconazole more likely than posaconazole increases plasma exposure to sublingual buprenorphine causing a risk of a clinically important interactionNARA Subscribed
European Journal of Clinical Pharmacology · 2016 · Vol. 72 · Issue 11 · Springer
Mari Fihlman; Tuija Hemmilä; Nora M. Hagelberg; Kristiina Kuusniemi; Janne T. Backman; Jouko Laitila; Kari Laine; Pertti J. Neuvonen; Klaus T. Olkkola; Teijo I. Saari
View Details View Full Text
Population pharmacokinetics of S-ketamine and norketamine in healthy volunteers after intravenous and oral dosingNARA Subscribed
European Journal of Clinical Pharmacology · 2015 · Vol. 71 · Issue 4 · Springer
Samuel Fanta; Mari Kinnunen; Janne T. Backman; Eija Kalso
View Details View Full Text
Effects of terbinafine and itraconazole on the pharmacokinetics of orally administered tramadolNARA Subscribed
European Journal of Clinical Pharmacology · 2015 · Vol. 71 · Issue 3 · Springer
Tuukka Saarikoski; Teijo I. Saari; Nora M. Hagelberg; Janne T. Backman; Pertti J. Neuvonen; Mika Scheinin; Klaus T. Olkkola; Kari Laine
View Details View Full Text
Fluconazole but not the CYP3A4 inhibitor, itraconazole, increases zafirlukast plasma concentrationsNARA Subscribed
European Journal of Clinical Pharmacology · 2012 · Vol. 68 · Issue 5 · Springer
Tiina Karonen; Jouko Laitila; Mikko Niemi; Pertti J. Neuvonen; Janne T. Backman
View Details View Full Text
No significant effect of the SLCO1B1 polymorphism on the pharmacokinetics of ursodeoxycholic acidNARA Subscribed
European Journal of Clinical Pharmacology · 2011 · Vol. 67 · Issue 11 · Springer
Xiaoqiang Xiang; Juha Vakkilainen; Janne T. Backman; Pertti J. Neuvonen; Mikko Niemi
View Details View Full Text
The CYP2C8 inhibitor gemfibrozil does not affect the pharmacokinetics of zafirlukastNARA Subscribed
European Journal of Clinical Pharmacology · 2011 · Vol. 67 · Issue 2 · Springer
Tiina Karonen; Pertti J. Neuvonen; Janne T. Backman
View Details View Full Text
Celecoxib is a CYP1A2 inhibitor in vitro but not in vivoNARA Subscribed
European Journal of Clinical Pharmacology · 2008 · Vol. 64 · Issue 5 · Springer
Marjo J. Karjalainen; Pertti J. Neuvonen; Janne T. Backman
View Details View Full Text
Effects of gender and moderate smoking on the pharmacokinetics and effects of the CYP1A2 substrate tizanidineNARA Subscribed
European Journal of Clinical Pharmacology · 2008 · Vol. 64 · Issue 1 · Springer
Janne T. Backman; Marika T. Schröder; Pertti J. Neuvonen
View Details View Full Text
Tolfenamic acid is a potent CYP1A2 inhibitor in vitro but does not interact in vivo: correction for protein binding is needed for data interpretationNARA Subscribed
European Journal of Clinical Pharmacology · 2007 · Vol. 63 · Issue 9 · Springer
Marjo J. Karjalainen; Pertti J. Neuvonen; Janne T. Backman
View Details View Full Text
Stereoselective interaction between the CYP2C8 inhibitor gemfibrozil and racemic ibuprofenNARA Subscribed
European Journal of Clinical Pharmacology · 2007 · Vol. 63 · Issue 5 · Springer
Aleksi Tornio; Mikko Niemi; Pertti J. Neuvonen; Janne T. Backman
View Details View Full Text
The CYP2C8 inhibitor gemfibrozil does not increase the plasma concentrations of zopicloneNARA Subscribed
European Journal of Clinical Pharmacology · 2006 · Vol. 62 · Issue 8 · Springer
Aleksi Tornio; Pertti J. Neuvonen; Janne T. Backman
View Details View Full Text
Montelukast and zafirlukast do not affect the pharmacokinetics of the CYP2C8 substrate pioglitazoneNARA Subscribed
European Journal of Clinical Pharmacology · 2006 · Vol. 62 · Issue 7 · Springer
Tiina Jaakkola; Janne T. Backman; Mikko Neuvonen; Mikko Niemi; Pertti J. Neuvonen
View Details View Full Text
Rifampicin is only a weak inducer of CYP1A2-mediated presystemic and systemic metabolism: studies with tizanidine and caffeineNARA Subscribed
European Journal of Clinical Pharmacology · 2006 · Vol. 62 · Issue 6 · Springer
Janne T. Backman; Marika T. Granfors; Pertti J. Neuvonen
View Details View Full Text
Itraconazole, gemfibrozil and their combination markedly raise the plasma concentrations of loperamideNARA Subscribed
European Journal of Clinical Pharmacology · 2006 · Vol. 62 · Issue 6 · Springer
Mikko Niemi; Aleksi Tornio; Marja K. Pasanen; Hanna Fredrikson; Pertti J. Neuvonen; Janne T. Backman
View Details View Full Text
Frequencies of single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide 1B1 SLCO1B1 gene in a Finnish populationNARA Subscribed
European Journal of Clinical Pharmacology · 2006 · Vol. 62 · Issue 6 · Springer
Marja K. Pasanen; Janne T. Backman; Pertti J. Neuvonen; Mikko Niemi
View Details View Full Text
Pioglitazone, an in vitro inhibitor of CYP2C8 and CYP3A4, does not increase the plasma concentrations of the CYP2C8 and CYP3A4 substrate repaglinideNARA Subscribed
European Journal of Clinical Pharmacology · 2006 · Vol. 62 · Issue 3 · Springer
Lauri I. Kajosaari; Tiina Jaakkola; Pertti J. Neuvonen; Janne T. Backman
View Details View Full Text
Isoniazid is a mechanism-based inhibitor of cytochrome P 450 1A2, 2A6, 2C19 and 3A4 isoforms in human liver microsomesNARA Subscribed
European Journal of Clinical Pharmacology · 2002 · Vol. 57 · Issue 11 · Springer
Xia Wen; Jun-Sheng Wang; Pertti J. Neuvonen; Janne T. Backman
View Details View Full Text
Selegiline pharmacokinetics are unaffected by the CYP3A4 inhibitor itraconazoleNARA Subscribed
European Journal of Clinical Pharmacology · 2001 · Vol. 57 · Issue 1 · Springer
Kari T. Kivistö; Jun-Sheng Wang; Janne T. Backman; Leena Nyman; Päivi Taavitsainen; Markku Anttila; Pertti J. Neuvonen
View Details View Full Text